HNC-1215

N/A

Report date: 2022/12/07 13:49:04
NME

Base Information

Drug NameHNC-1215
Drug Alias NameHNC-1215HNC1215（2.1类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Henovcom Bioscience Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Henovcom Bioscience Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A